Raymond James Initiates Coverage On MetLife with Market Perform Rating
Raymond James analyst Wilma Burdis initiates coverage on MetLife (NYSE:MET) with a Market Perform rating.
Credit Suisse Maintains Outperform on MetLife, Raises Price Target to $77
Credit Suisse analyst Andrew Kligerman maintains MetLife (NYSE:MET) with a Outperform and raises the price target from $68 to $77.
Animal Spirits: Nasdaq Up 19% Off June Lows
MARKET UPDATE After a 3-week S&P 500 rally, U.S. markets catching Canadian market Year-to-date in Canadian dollars S&P…
Wolfe Research Upgrades MetLife to Outperform, Raises Price Target to $74
Wolfe Research upgrades MetLife (NYSE:MET) from Peer Perform to Outperform and raises the price target from $70 to $74.
Analyzing MetLife’s Short Interest
MetLife's (NYSE:MET) short percent of float has risen 29.57% since its last report. The company recently reported that it has 10.22 million shares sold short, which is 1.49% of all regular shares that are available for trading.
Elon Musk Weighs In On Gun Control, ‘Homicide Insurance’ Following Uvalde School Mass Shooting
In the wake of another mass shooting, this time at Robb Elementary School in Uvalde, Texas, where 19 students and two teachers were gunned down on Tuesday, Tesla Inc (NASDAQ:
Analyst Ratings for MetLife
Over the past 3 months, 4 analysts have published their opinion on MetLife (NYSE:MET) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Citigroup Initiates Coverage On MetLife with Buy Rating, Announces Price Target of $77
Citigroup analyst Michael Ward initiates coverage on MetLife (NYSE:MET) with a Buy rating and announces Price Target of $77.
Expert Ratings for MetLife
MetLife (NYSE:MET) has observed the following analyst ratings within the last quarter: